Integrated Diagnostics Share Forecast, Price & News

GBX 1.23
+0.04 (+3.38 %)
(As of 07/27/2021 09:41 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume18,087 shs
Average Volume200,908 shs
Market Capitalization£7.35 million
P/E Ratio7.38
Dividend Yield8.08%
30 days | 90 days | 365 days | Advanced Chart
Receive IDHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

About Integrated Diagnostics

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 31, 2020, it operated a network of 481 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.19 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Integrated Diagnostics (LON:IDHC) Frequently Asked Questions

What stocks does MarketBeat like better than Integrated Diagnostics?

Wall Street analysts have given Integrated Diagnostics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Integrated Diagnostics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Integrated Diagnostics' next earnings date?

Integrated Diagnostics is scheduled to release its next quarterly earnings announcement on Tuesday, August 31st 2021.
View our earnings forecast for Integrated Diagnostics

How has Integrated Diagnostics' stock price been impacted by Coronavirus (COVID-19)?

Integrated Diagnostics' stock was trading at GBX 4.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IDHC stock has decreased by 71.6% and is now trading at GBX 1.23.
View which stocks have been most impacted by COVID-19

How often does Integrated Diagnostics pay dividends? What is the dividend yield for Integrated Diagnostics?

Integrated Diagnostics declared a dividend on Thursday, June 17th. Stockholders of record on Thursday, July 8th will be given a dividend of GBX 0.05 per share on Thursday, July 29th. This represents a dividend yield of 4.38%. The ex-dividend date of this dividend is Thursday, July 8th. The official announcement can be seen at this link.
View Integrated Diagnostics' dividend history

Is Integrated Diagnostics a good dividend stock?

Integrated Diagnostics pays an annual dividend of GBX 0.74 per share and currently has a dividend yield of 8.08%. IDHC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Integrated Diagnostics is 444.43%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Integrated Diagnostics' dividend history.

Who are Integrated Diagnostics' key executives?

Integrated Diagnostics' management team includes the following people:
  • Dr. Hend El Sherbini, Group CEO & Exec. Director (Age 52)
  • Mr. Omar Bedewy, VP of Fin. & Strategy
  • Dr. Eissa Khorshid, Chief Operating Officer
  • Nancy Fahmy, Investor Relations Director
  • Mr. Mohamed Kamel Saleh, Gen. Counsel (Age 39)
  • Dr. Seham Ibrahim, Sales Director (Age 52)
  • Dr. Moushira El Saifi, Head of Hematology Department
  • Dr. Mohamed Akram Abdel-Rahman Nouh, Head of Pathology Department and Information Technology Administrator
  • Dr. Osama S. Zaghloul, Managing Director of Ultralab (Age 61, Pay $176.14k)
  • Dr. Amid Abdelnour, Managing Director of Biolab (Age 62)

Who are some of Integrated Diagnostics' key competitors?

What other stocks do shareholders of Integrated Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integrated Diagnostics investors own include Georgia Healthcare Group PLC (GHG.L) (GHG), VEON (VEON), Pao Tmk (TMKXY) and M.P. Evans Group (MPE).

What is Integrated Diagnostics' stock symbol?

Integrated Diagnostics trades on the London Stock Exchange (LON) under the ticker symbol "IDHC."

How do I buy shares of Integrated Diagnostics?

Shares of IDHC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Integrated Diagnostics' stock price today?

One share of IDHC stock can currently be purchased for approximately GBX 1.23.

How much money does Integrated Diagnostics make?

Integrated Diagnostics has a market capitalization of £7.35 million.

How many employees does Integrated Diagnostics have?

Integrated Diagnostics employs 5,611 workers across the globe.

What is Integrated Diagnostics' official website?

The official website for Integrated Diagnostics is www.idhcorp.com.

Where are Integrated Diagnostics' headquarters?

Integrated Diagnostics is headquartered at 12 Castle Street, SAINT HELIER, JE2 3RT, Jersey.

How can I contact Integrated Diagnostics?

Integrated Diagnostics' mailing address is 12 Castle Street, SAINT HELIER, JE2 3RT, Jersey. The company can be reached via phone at +44-1534-847000.

This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.